Ashwin Kishtagari, MBBS, is Assistant Professor of Medicine in the division of hematology and oncology at Vanderbilt ...
Analysis of 2823 adult patients with acute myeloid leukemia (AML) revealed that overall survival decreases almost linearly with increasing age across all European LeukemiaNet (ELN) genetic-risk groups ...
A new review article outlines the latest research and results into programmed cell death-1/programmed cell death ligand-1 (PD-1/PD-L1) inhibitors for the treatment of myelodysplastic syndromes (MDS) ...
New Insight Into the Biology, Risk Stratification, and Targeted Treatment of Myelodysplastic Syndromes AML is a therapeutically challenging, heterogeneous disease in need of improved therapy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results